Topic: Cholesterol
ATLANTA (Reuters) - Adding a triglyceride-lowering drug to cholesterol-fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study. The study run by the National Institutes of Health, dubbed Accord, aimed to see if the dual-drug therapy could reduce cardiovascular events in diabetes patients ...
People are always getting confused about the two types of cholesterol found in the blood stream. In this article, we will differentiate between HDL (high density lipoprotein), or the ?good guys? and LDL (low density lipoprotein), or the ?bad guys?. So, yes not all cholesterol is bad for you.
The levels of HDL cholesterol and LDL cholesterol in the blood ...
VYTORIN STUDY: A safety monitoring board doing a planned interim analysis of a long study of Merck's Vytorin cholesterol pill decided there are no serious safety problems, so the study can continue. ANALYSTS' TAKE: That result was generally expected, and Vytorin sales likely will ...
Sales of Merck & Co.'s blockbuster cholesterol drug Vytorin likely will continue to fall amid rising competition from rival brands and generic versions in the same class of pills, an analyst predicted Friday. Bernstein Research analyst Tim Anderson gave his assessment after the drugmaker ...
